PD-L1-containing exosomes have been involved in tumor progression in preclinical malignant glioma models; exosomal PD-L1 secreted by glioblastoma stem-like cells inhibited the activation of CD4+ and CD8+ immune effector cells [38]. This evidence concerns the gene CD4 and neoplasm.